Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Power List / 2021 / Power List / Ian Wilson

Ian Wilson

Professor of Drug Metabolism and Molecular Toxicology, Imperial College London, UK

  • Profile

Meet Ian Wilson

Predictions? Realistically, I hope a lot more will be done to “democratize” analytical science. Things like microsampling at home by the patient; putting an ion mobility spectrometer on your smartphone to tell you that you have drunk too much (easy) or that you might have cancer (I’m sure there’s an app for that!); or making miniature mass and NMR spectrometers that are reliable enough to put on a GP’s desk to properly individualize medicine through metabolic phenotyping. I suggest that, if Jim Lovelock could get a mini GC-MS on a Mariner spacecraft to Mars in the 1970’s on the “Viking” mission, we should be able to get them into community medical practices in less than a decade (we will of course need the software to remove the analyst from the interpretation of the data but that is what AI is for...).

Advice? Don’t follow in my footsteps, I’m happy to get out of the way. LEAD!

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.